The following content is sponsored by Americans for Limited Government.
For years, Washington let a critical federal healthcare program morph into something Congress never intended. What began as a lifeline for vulnerable patients has slowly become a multibillion-dollar windfall for powerful hospitals, with too little transparency, too little accountability, and far too many opportunities for abuse.
Politicians ignored the warning signs for far too long. President Donald Trump is finally doing something about it.
This week, the Trump administration unveiled a pilot program to modernize the 340B Drug Pricing Program — a commonsense reform that replaces automatic upfront discounts for hospitals with a rebate model for a limited number of...
Read the full article here